Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 43.32% vs 11.20% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 58.94% vs 25.15% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 0.00% vs 53.62% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is -1.01% vs -6.01% in Mar 2025
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
4.41
24.04
545.12%
Share Warrants & Outstandings
Total Reserve
118.20
192.63
-74.43
-38.64%
Shareholder's Funds
150.42
197.04
-46.62
-23.66%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.97
0.00
0.97
0.00%
Secured Loans
0.97
0.00
0.97
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.77
-1.42
2.19
154.23%
Other Long Term Liabilities
0.00
4.85
-4.85
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
1.75
3.43
-1.68
-48.98%
Current Liabilities
Trade Payables
81.59
8.10
73.49
907.28%
Other Current Liabilities
12.38
8.45
3.93
46.51%
Short Term Borrowings
48.99
0.00
48.99
0.00%
Short Term Provisions
2.12
6.59
-4.47
-67.83%
Total Current Liabilities
145.08
23.15
121.93
526.70%
Total Liabilities
297.25
223.61
73.64
32.93%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.39
38.39
5.00
13.02%
Less: Accumulated Depreciation
25.73
26.85
-1.12
-4.17%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
17.66
11.55
6.11
52.90%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
8.12
46.12
-38.00
-82.39%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
27.02
-24.90
-92.15%
Long Term Loans & Advances
5.53
3.64
1.89
51.92%
Other Non Current Assets
0.88
32.28
-31.40
-97.27%
Total Non-Current Assets
34.30
128.52
-94.22
-73.31%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
41.54
13.63
27.91
204.77%
Sundry Debtors
129.65
24.36
105.29
432.22%
Cash and Bank
1.40
53.11
-51.71
-97.36%
Other Current Assets
3.30
1.97
1.33
67.51%
Short Term Loans and Advances
87.05
2.01
85.04
4,230.85%
Total Current Assets
262.94
95.09
167.85
176.52%
Net Current Assets (Including Current Investments)
117.87
71.94
45.93
63.84%
Total Current Assets Excluding Current Investments
262.94
95.09
167.85
176.52%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
297.25
223.61
73.64
32.93%
Contingent Liabilities
0.00
17.20
-17.20
-100.00%
Total Debt
49.96
0.00
49.96
0.00%
Book Value per share (adjusted)
51.54
446.47
-394.93
-88.46%
Annual - Borrowings
Borrowings 49.96 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 43.32% vs 11.20% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 25.78 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 58.94% vs 25.15% in Mar 2025
Annual - Investments
Investments 2.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs 53.62% in Mar 2025
Annual - Current Assets
Current Assets 262.94 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.01% vs -6.01% in Mar 2025